Bio-Rad Laboratories, Inc.Class A

BIONYSEUSD
291.11 USD
4.04 (1.37%)🟢LIVE (AS OF 02:17 PM EDT)
🟢Market: OPEN

Bio-Rad Laboratories, Inc.Class A (BIO) is currently trading at $291.11. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. On valuation, BIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jul 6, 2026.

Open?$291.48
High?$292.53
Low?$290.07
Prev. Close?$295.15
Volume?64.0K
Avg. Volume?369.0K
VWAP?$291.25
Rel. Volume?0.17x
Bid / Ask
Bid?$290.74 × 40
Ask?$291.40 × 520
Spread?$0.66
Midpoint?$291.07
Valuation & Ratios
Market Cap?7.9B
Shares Out?21.7M
Float?18.1M
Float %?83.4%
P/E Ratio?46.79
P/B Ratio?1.15
EPS?$6.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
7.9B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1980-02-29
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
79
Momentum?
60
Short Sent.?
40
Piotroski F-Score?3/9Weak
Altman Z-Score?3.30Safe
Confidence?64%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.41%Elevated
Short Interest?1.5M
Days to Cover?4.4
Free Float18.1M
Avg Daily Volume347.4K
Settlement Date2026-06-15
Financial Health
Current Ratio?3.21Strong
Quick Ratio?2.37Strong
Cash Ratio?0.55Adequate
Debt/Equity?0.18Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
61/100
P/E?
Peers
50
S&P
14
46.8PRICEY
P/B?
Peers
100
S&P
94
1.15CHEAP
P/S?
Peers
91
S&P
50
3.05FAIR
P/FCF?
Peers
91
S&P
48
22.1FAIR
EV/EBITDA?
Peers
36
S&P
7
37.3HIGH
EV/Sales?
Peers
91
S&P
56
3.32FAIR
Returns & Efficiency
ROE?
Peers
22
S&P
17
2.5%WEAK
ROA?
Peers
10
S&P
17
1.7%WEAK
Cash Flow & Enterprise
FCF?$357.2M
Enterprise Value?$8.6B
Fundamentals ratios updated end of day